SCHEMBL26570936

SCHEMBL26570936

N/C(=N\N=C(/N)c1ccccc1O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 7/20 0.47
▸ KDM4E B2RXH2 5/20 0.47
▸ ALDH1A1 P00352 4/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ MAPT P10636 2/20 0.47
▸ TSHR P16473 1/20 0.47
▸ NPC1 O15118 4/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ CA1 P00915 2/20 0.43
▸ CA9 Q16790 2/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ HMGB1 P09429 1/20 0.43
▸ CA4 P22748 1/20 0.43
▸ CA6 P23280 1/20 0.43
▸ CA7 P43166 1/20 0.43
▸ NAPRT Q6XQN6 1/20 0.43
▸ CA14 Q9ULX7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18938347 0.82 KMT2A (0.61) HSD17B10MAPTTSHRNPC1MEN1
SCHEMBL12159938 0.74 HPGD (0.54) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL3082608 0.74 HPGD (0.54) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL20017352 0.72 MEN1 (0.50) HSD17B10MAPTTSHRNPC1MEN1
SCHEMBL1780479 0.72 KDM4E (0.52) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL15780742 0.72 KDM4E (0.52) HPGDKDM4EALDH1A1HSD17B10MAPT
Hydrochloric Acid SCHEMBL9156571 0.72 KMT2A (0.55) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL24022828 0.71 NPC1 (0.61) NPC1MEN1KMT2ASMN1; SMN2POLB
SCHEMBL22044257 0.71 CYP2D6 (0.66) KDM4EALDH1A1MAPTNPC1MEN1
SCHEMBL13770411 0.70 KMT2A (0.52) HSD17B10MAPTTSHRNPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230332197-A1 NUCLEOSIDES AND NUCLEOTIDES WITH 3' VINYL BLOCKING GROUP ILLUMINA, INC. 2023-10-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230332197-A1 NUCLEOSIDES AND NUCLEOTIDES WITH 3' VINYL BLOCKING GROUP NT5C3B, NSUN2, DUT HPGD 3155/4885KDM4E 807/4885ALDH1A1 2258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback